<DOC> 
<DOCNO>1091014_business_story_11612350.utf8</DOCNO> 
<TEXT> 
         
The Telegraph - Calcutta (Kolkata) | Business | Merck acquires Bangalore firm
                                                                                                               Merck acquires Bangalore firm
          OUR SPECIAL CORRESPONDENT                               
	Mumbai, Oct. 13: Merck KgaA  the German pharmaceutical and chemical firm  has acquired Bangalore Genei (India) Pvt Ltd (BGIP) for an undisclosed sum.         
	BGIP is engaged in the development, production, marketing and sales of products for genomic research.         
	The acquisition will be done by Mercks wholly owned subsidiary in India  Merck Specialities Pvt Ltd  and the stake will be bought from the Sanmar group. The move is expected to make Merck a leading bioscience company in India.         
	BGIP, which has more than 100 employees, had generated revenues of Rs 20.2 crore in 2008-09.         
	Christina Shasserre, global head of Mercks bioscience business, said BGIPs leadership in the Indian genomic research market  a segment with high growth potential  should complement Mercks existing customer base.         
	BGIPs product portfolio comprises a wide range of bioscience products, which are tailored according to the needs of the domestic market, she said.         
	Merck had garnered revenues of euro 7.6 billion in 2008. The Merck family holds 70 per cent in the Germany-based firm, while shareholders own the rest.         
	The US subsidiary, Merck amp; Company, has been operating as an independent firm since 1917.         
	Merck Ltd (India) plans to launch over 25 products this year. The group is targeting revenues worth euro 500 million by 2012 in the country.         
	Among therapeutic products, Merck has a presence in cardiovascular, antibiotic, diabetes care, dermatological, oncological and cough and cold segments.                                                                                                                                        
</TEXT> 
</DOC>